€121.25
0.12% yesterday
Xetra, May 08, 05:35 pm CET
ISIN
DE0006599905
Symbol
MRK
Index
Sector
Industry

Merck Stock price

€121.25
+5.25 4.53% 1M
-29.60 19.62% 6M
-18.65 13.33% YTD
-32.90 21.34% 1Y
-42.20 25.82% 3Y
+15.15 14.28% 5Y
+21.00 20.95% 10Y
Xetra, Closing price Thu, May 08 2025
+0.15 0.12%
ISIN
DE0006599905
Symbol
MRK
Index
Sector
Industry

Key metrics

Market capitalization €52.72b
Enterprise Value €60.58b
P/E (TTM) P/E ratio 18.98
EV/FCF (TTM) EV/FCF 21.00
EV/Sales (TTM) EV/Sales 2.86
P/S ratio (TTM) P/S ratio 2.49
P/B ratio (TTM) P/B ratio 1.76
Dividend yield 1.81%
Last dividend (FY24) €2.20
Revenue growth (TTM) Revenue growth 0.78%
Revenue (TTM) Revenue €21.16b
EBIT (operating result TTM) EBIT €4.53b
Free Cash Flow (TTM) Free Cash Flow €2.88b
Cash position €2.52b
EPS (TTM) EPS €6.39
P/E forward 16.71
P/S forward 2.44
EV/Sales forward 2.80
Show more

Create a Free Account to create an Merck alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Merck Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Merck forecast:

15x Buy
83%
2x Hold
11%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a Merck forecast:

Buy
83%
Hold
11%
Sell
6%

Financial data from Merck

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
21,156 21,156
1% 1%
100%
- Direct Costs 8,671 8,671
1% 1%
41%
12,485 12,485
1% 1%
59%
- Selling and Administrative Expenses 3,546 3,546
4% 4%
17%
- Research and Development Expense 2,279 2,279
7% 7%
11%
6,660 6,660
6% 6%
31%
- Depreciation and Amortization 2,134 2,134
14% 14%
10%
EBIT (Operating Income) EBIT 4,526 4,526
3% 3%
21%
Net Profit 2,776 2,776
2% 2%
13%

In millions EUR.

Don't miss a Thing! We will send you all news about Merck directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merck Stock News

AD HOC NEWS
11 days ago
Die US-Investmentbank Goldman Sachs hat die Einstufung für Merck KGaA DE0006599905 mit einem Kursziel von 169 Euro auf "Buy" belassen.
AD HOC NEWS
11 days ago
Der Darmstädter MerckDE0006599905-Konzern schluckt wie erwartet den US-Krebsspezialisten Springworks Therapeutics US85205L1070.
AD HOC NEWS
11 days ago
Der Darmstädter MerckDE0006599905-Konzern schluckt den US-Krebsspezialisten Springworks Therapeutics US85205L1070.
More Merck News

Company Profile

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Head office Germany
CEO Belén López
Employees 62,557
Founded 1995
Website www.merckgroup.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today